An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression
Research over the last two decades has established ketamine as a safe, effective, fast-acting, and sustained antidepressant that significantly reduces adverse symptoms associated with depression, even in patients who are treatment resistant. Much of this research has evolved within the framework of...
Enregistré dans:
Auteurs principaux: | Sherry-Anne Muscat, Glenn Hartelius, Courtenay Richards Crouch, Kevin W. Morin |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a499c78a4b10447d8cf867dd4fa082f1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Immunoregulation and antidepressant effect of ketamine
par: Zhang Nan, et autres
Publié: (2021) -
Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy
par: Anya Ragnhildstveit, et autres
Publié: (2021) -
Procedural moderate sedation with ketamine in pediatric critical care unit
par: Tarek R Hazwani, et autres
Publié: (2017) -
Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
par: Mateusz Kowalczyk, et autres
Publié: (2021) -
Deficits in N-Methyl-D-Aspartate Receptor Function and Synaptic Plasticity in Hippocampal CA1 in APP/PS1 Mouse Model of Alzheimer’s Disease
par: Le Xu, et autres
Publié: (2021)